Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Adv Nanobiomed Res. 2021 Mar 13;1(8):2100021. doi: 10.1002/anbr.202100021

Table 2:

List of p-values for effect of the CpG-PBNP-PTT on tumor progression in a synchronous, 9464D TH-MYCN murine model of NB (Figure 6; Supplementary Figure. 6)

Tukey’s multiple comparisons test Adjusted p-value
Primary Tumor Day 43
Vehicle vs. PBNP 0.0001
Vehicle vs. CpG-PBNP <0.0001
Vehicle vs. PBNP-PTT (120) <0.0001
Vehicle vs. CpG-PBNP-PTT (120) <0.0001
PBNP vs. CpG-PBNP 0.3497
PBNP vs. PBNP-PTT (120) 0.0010
PBNP vs. CpG-PBNP-PTT (120) 0.0010
CpG-PBNP vs. PBNP-PTT (120) 0.2159
CpG-PBNP vs. CpG-PBNP-PTT (120) 0.2159
PBNP-PTT (120) vs. CpG-PBNP-PTT (120) >0.9999
Secondary Tumor Day 43
Vehicle vs. PBNP 0.0043
Vehicle vs. CpG-PBNP 0.0001
Vehicle vs. PBNP-PTT (120) <0.0001
Vehicle vs. CpG-PBNP-PTT (120) <0.0001
PBNP vs. CpG-PBNP 0.8977
PBNP vs. PBNP-PTT (120) 0.0407
PBNP vs. CpG-PBNP-PTT (120) 0.0139
CpG-PBNP vs. PBNP-PTT (120) 0.3010
CpG-PBNP vs. CpG-PBNP-PTT (120) 0.1476
PBNP-PTT (120) vs. CpG-PBNP-PTT (120) 0.9960
Secondary Tumor Day 50
CpG-PBNP vs. PBNP-PTT (120) <0.0001
CpG-PBNP vs. CpG-PBNP-PTT (120) <0.0001
PBNP-PTT (120) vs. CpG-PBNP-PTT (120) 0.9201